v3.24.3

EARNINGS (LOSS) PER SHARE (Schedule of outstanding shares of common stock equivalents were excluded from the calculation due to their antidilutive nature) (Details) - shares | 3 Months Ended | 9 Months Ended
--- | --- | ---
Sep. 30, 2024 | Sep. 30, 2023 | Sep. 30, 2024 | Sep. 30, 2023
Earnings Per Share [Abstract] |  |  |  |  |
Stock-based awards |  | 2,552,867 | 1,072,938 | 2,055,632 | 0
Notes 2025 |  | 0 | 2,276,818 | 1,510,363 | 0
Notes 2029 | [1] | 984,342 | 0 | 392,152 | 0
Total shares excluded |  | 3,537,209 | 3,349,756 | 3,958,147 | 0
[1] | In conjunction with the issuance of the Notes 2029 in June 2024, the Company used approximately $25,230 of the net proceeds from this offering to pay the cost of the capped call transactions. In July 2024, following an additional issuance of the Notes 2029, $3,111 of net proceeds were used to pay the cost of capped call transactions. In accordance with FASB ASC 260, antidilutive contracts, such as purchased call options are excluded from the computation of diluted net income (loss) per share. Accordingly, any potential impact resulting from capped call transaction is excluded from our computation of diluted net income (loss) per share.

X
- Definition Represents the number of antidilutive shares for notes Due. + References No definition available. + Details
Name: | sedg_AntidilutiveNotesDue
Namespace Prefix: | sedg_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Information about antidilutive notes due 2029 excluded from computation of earnings per share. + References No definition available. + Details
Name: | sedg_AntidilutiveNotesDue2029ExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix: | sedg_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the number of antidilutive shares for stock-based awards. + References No definition available. + Details
Name: | sedg_AntidilutiveStockBasedAwards
Namespace Prefix: | sedg_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration